Sign Out
Pregnancy: Safety of SKYVaricella has not been evaluated in pregnant women. Direct and/or indirect adverse effect related to reproductive and developmental toxicity has not been observed in animal studies. However, SKYVaricella should not be administered to pregnant women since wild-type varicella (natural infection) is known to sometimes cause fetal harm. Furthermore, pregnancy should be avoided for 3 months following vaccination.
Breast-feeding: It is not known whether live attenuated varicella virus is excreted in human milk. However, because some viruses are excreted in human milk, caution should be exercised if SKYVaricella is administered to nursing mothers.
Fertility: No human fertility data are available. Animal data have not shown effects on female fertility. Male fertility has not been assessed in animals.
